Scrambler therapy offers hope for young cancer survivors with nerve pain
NCT ID NCT05357469
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study looks at whether Scrambler therapy can safely reduce painful nerve damage caused by chemotherapy in adolescents and young adults (ages 15-39) who have finished active cancer treatment. Participants are randomly assigned to receive the therapy right away or after a waiting period. The goal is to see if this treatment improves pain, physical function, and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PAINFUL PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
- Wearable insoles warn of foot pressure to stop diabetic ulcers
- New bladder cancer drug aims to fight tumors without harming nerves
- Acupuncture with a jolt: could needles shield nerves from chemo?
- Acupuncture needles aim to stop Chemo's nerve pain
- Freezing pain away: yale tests Nerve-Blocking procedure for Long-Term relief